---
figid: PMC6695603__ijms-20-03821-g004
figlink: /pmc/articles/PMC6695603/figure/ijms-20-03821-f004/
number: Figure 4
caption: In EGFR mutant NSCLC without targetable resistant mutations, activation of
  YAP enhances the downstream genes expression of EGFs, ERBB3, ERBB4, CTGF, and CYR61
  to form an autocrine loop and reinforce MAPK signaling pathway to induce cancer
  progression, drugs resistance, and immune escape. YAP blockade by MEK 1/2, CDK1,
  CDK9, and YAP-TEAD complex inhibitors in combination with anti-PD-1/PD-L1 ICIs may
  be a future therapeutic strategy for the treatment of EGFR mutant NSCLC without
  targetable resistant mutations.
pmcid: PMC6695603
papertitle: Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein
  (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell
  Lung Cancer (NSCLC).
reftext: Ping-Chih Hsu, et al. Int J Mol Sci. 2019 Aug;20(15):3821.
pmc_ranked_result_index: '12344'
pathway_score: 0.9611997
filename: ijms-20-03821-g004.jpg
figtitle: Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein
  (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell
  Lung Cancer (NSCLC).
year: '2019'
organisms: Homo sapiens
ndex: 90796b20-ded8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6695603__ijms-20-03821-g004.html
  '@type': Dataset
  description: In EGFR mutant NSCLC without targetable resistant mutations, activation
    of YAP enhances the downstream genes expression of EGFs, ERBB3, ERBB4, CTGF, and
    CYR61 to form an autocrine loop and reinforce MAPK signaling pathway to induce
    cancer progression, drugs resistance, and immune escape. YAP blockade by MEK 1/2,
    CDK1, CDK9, and YAP-TEAD complex inhibitors in combination with anti-PD-1/PD-L1
    ICIs may be a future therapeutic strategy for the treatment of EGFR mutant NSCLC
    without targetable resistant mutations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - YY1AP1
  - MAPK1
  - AREG
  - CDK1
  - CDK9
  - CTGF
  - CYR61
  - MAPK3
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK13
  - MAPK12
  - MAP2K1
  - MAP2K2
  - PDCD1
  - ERBB3
  - ERBB4
  - EGFR
  - EGF
  - H
  - NSCLC
  - PD-LI
  - metastasis
genes:
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AREG,NRG-1.etc),
  symbol: AREG
  source: hgnc_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: CDK9
  symbol: CDK9
  source: hgnc_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CTGF/CYR61
  symbol: CTGF
  source: hgnc_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: CTGF/CYR61
  symbol: CYR61
  source: hgnc_symbol
  hgnc_symbol: CYR61
  entrez: '3491'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ERBB4
  symbol: ERBB4
  source: hgnc_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
chemicals:
- word: H
  source: MESH
  identifier: D006859
diseases:
- word: NSCLC
  source: MESH
  identifier: D002289
- word: PD-LI
  source: MESH
  identifier: D010300
- word: metastasis
  source: MESH
  identifier: D009362
---
